Marijuana Use Is Not Associated With Liver Fibrosis Progression in HCV/HIV Co-infected Women

被引：0
|
作者：
Kelly, Erin [1 ]
Dodge, Jennifer L. [1 ]
Sarkar, Monika [1 ]
French, Audrey [2 ]
Tien, Phyllis [1 ]
Glesby, Marshall [3 ]
Golub, Elizabeth T. [4 ]
Augenbraun, Michael [5 ]
Plankey, Michael [6 ]
Peters, Marion G. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[3] Cornell, Infect Dis, New York, NY USA
[4] Johns Hopkins, Baltimore, MD USA
[5] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[6] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1472
引用
收藏
页码：905A / 906A
页数：2
相关论文
共 50 条
  • [41] SERUM FERRITIN AND FIBROBLAST GROWTH FACTOR 23 ARE ASSOCIATED WITH LIVER FIBROSIS DIAGNOSED BY TRANSIENT ELASTOGRAPHY IN HIV/HCV CO-INFECTED PATIENTS
    Sebastiani, Giada
    Wagner, John
    Rollet, Kathleen
    Klein, Marina
    Pantopoulos, Kostas
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : E151 - E151
  • [42] Usefulness of the AST to platelet ratio index (APRI) for predicting liver fibrosis in HIV/HCV co-infected patients
    Carvalho Filho, R. J.
    Narciso, J. L.
    Schiavon, L. L.
    Sampaiol, J. P.
    Lanzoni, V. P.
    Ferraz, M. L. G.
    Silva, A. E. B.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S189 - S190
  • [43] The influence of the PNPLA3 polymorphism on hepatic steatosis and fibrosis progression in HIV-HCV co-infected patients
    Payer, B.
    Reiberger, T.
    Stift, J.
    Ferenci, P.
    Peck-Radosavljevic, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (15-16) : 570 - 570
  • [44] Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
    Mohammad-Ali Jenabian
    Ido Kema
    Robert Paulino Ramirez
    Sahar Saeed
    Kathleen Rollet
    Kishanda Vyboh
    Jean-Carlos Tejada
    Norbert Gilmore
    Marina B Klein
    Jean-Pierre Routy
    BMC Infectious Diseases, 14 (Suppl 2)
  • [45] PLASMA CELLS ARE PRESENT IN LIVER BIOPSIES OF HIV/HCV CO-INFECTED PATIENTS
    Vachon, Marie-Louise C.
    Branch, Andrea D.
    Dieterich, Douglas T.
    Fiel, M. Isabel
    HEPATOLOGY, 2010, 52 (04) : 1230A - 1230A
  • [46] Outcomes could be improved in HCV–HIV co-infected liver transplant recipients
    Natalie J. Wood
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (4) : 190 - 190
  • [47] Severity of liver disease in Hispanic patients co-infected with HCV-HIV.
    Rodriguez-Torres, M
    Rodriguez, JF
    HEPATOLOGY, 2001, 34 (04) : 231A - 231A
  • [48] DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV
    El-Garem, Hassan
    AbdAllah, Mohamed
    Omar, Heba
    Cordie, Ahmed
    Alem, Shereen Abdel
    Elzahry, Mohamad A. Mohey Eldin
    Ghaith, Doaa
    Abou El- Soud, Neveen H.
    Kamal, Walid
    Elsharkawy, Aisha
    Esmat, Gamal
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (07) : 693 - 698
  • [49] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
    Bollepalli, S
    Mahthieson, K
    Post, J
    Hillier, A
    Nadir, A
    HEPATOLOGY, 2005, 42 (04) : 423A - 423A
  • [50] The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients
    Carrieri, Maria Patrizia
    Protopopescu, Camelia
    Marcellin, Fabienne
    Wittkop, Linda
    Lacombe, Karine
    Esterle, Laure
    Sogni, Philippe
    Salmon-Ceron, Dominique
    JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 845 - 847
12345